Exploring a New Use for Umbilical Cord Tissue: Could It Help Repair Spina Bifida?
A new clinical trial exploring umbilical cord tissue is being conducted by The University of Texas Health Science Center at Houston.
Titled Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects, the study aims to investigate whether a baby’s own umbilical cord tissue can be used as a patch during surgery to repair an open neural tube defect.
Open neural tube defects occur when the neural tube, which develops into the brain and spinal cord, does not close completely during early pregnancy. One example is myelomeningocele, the most severe form of spina bifida.
In affected babies, part of the spinal cord and its surrounding structures can protrude through an opening in the spine. Surgical closure is required to protect the exposed tissue and reduce the risk of further complications.
Lead by Dr. Stephen Fletcher, the researchers are investigating whether tissue collected from the baby’s own umbilical cord can provide an alternative material for closing the dura, the protective membrane surrounding the spinal cord.
What have previous studies discovered?
The new trial isn’t the first time researchers have explored umbilical cord tissue in the treatment of spina bifida.
Previous studies have investigated whether cord tissue could be used as a biological patch to help protect the spinal cord during surgery.
Promising findings from earlier research
A study published in the Journal of Neurosurgery: Pediatrics investigated the use of cryopreserved, decellularised human umbilical cord matrix during prenatal surgery for myelomeningocele.
The study followed 57 children who underwent fetoscopic surgery using an umbilical cord tissue patch in the period 2016-2022.
Researchers reported encouraging surgical outcomes, including:
- No cases of cerebrospinal fluid leakage at birth.
- Only two children requiring surgical revision following superficial wound separation.
- At approximately 30 months, 54.8% of children assessed were independently walking.
These findings demonstrated the potential of umbilical cord tissue as a biological material for surgical repair.
Further clinical research in 2026
Research published in the American Journal of Obstetrics and Gynecology in August 2026 continued investigating the use of human umbilical cord tissue during fetoscopic spina bifida repair.
The non-randomised clinical trial included 49 babies who underwent prenatal surgery using a human umbilical cord patch.
Researchers achieved successful surgical closure in all 49 cases. They also reported that 53% of mothers in the fetoscopic group delivered vaginally, compared with 1% in a historical group who underwent open fetal surgery.
These studies are important because they provide human clinical experience with umbilical cord tissue in surgical applications. However, they used donated cord tissue during prenatal procedures, rather than the baby’s own tissue after birth.
What makes the new trial particularly interesting?
The latest trial takes the research one step further by investigating the use of a baby’s own umbilical cord tissue, rather than tissue donated by another individual. The study aims to recruit 15 newborns and is expected to continue through to 2033.
Looking towards the future of regenerative medicine
The medical potential of umbilical cord blood and tissue continues to be an exciting area of scientific investigation.
From established cord blood stem cell treatments to emerging research involving umbilical cord tissue, each new study adds to our understanding of what may be possible.
For parents preparing to welcome a new baby, cord blood and tissue banking offer an opportunity to preserve valuable biological resources at a time when they would otherwise be discarded.
At CordBank, we believe every parent should have the opportunity to understand the potential of their baby’s cord blood and tissue and make an informed decision about preserving them.